Strides Pharma Science Ltd
NSE:STAR
Strides Pharma Science Ltd
NSE:STAR
Price:
669.55
INR
0.42%
Market Closed
Market Cap:
61.7B
INR
Balance Sheet
Balance Sheet Decomposition
Strides Pharma Science Ltd
Strides Pharma Science Ltd
| Current Assets | 30.9B |
| Cash & Short-Term Investments | 3.4B |
| Receivables | 12.5B |
| Other Current Assets | 15.1B |
| Non-Current Assets | 29B |
| Long-Term Investments | 3.9B |
| PP&E | 10B |
| Intangibles | 11.3B |
| Other Non-Current Assets | 3.7B |
Balance Sheet
Strides Pharma Science Ltd
Strides Pharma Science Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
1 020
|
2 193
|
3 295
|
2 376
|
3 606
|
1 558
|
1 253
|
1 693
|
3 035
|
1 610
|
|
| Cash |
1 020
|
2 193
|
0
|
2 376
|
3 606
|
1 558
|
1 253
|
1 693
|
1 125
|
883
|
|
| Cash Equivalents |
0
|
0
|
3 295
|
0
|
0
|
0
|
0
|
0
|
1 910
|
727
|
|
| Short-Term Investments |
6 367
|
12 925
|
14 060
|
3 694
|
4 311
|
1 916
|
1 496
|
149
|
572
|
1 285
|
|
| Total Receivables |
4 395
|
12 634
|
10 031
|
10 856
|
12 098
|
10 816
|
12 454
|
18 898
|
15 005
|
14 024
|
|
| Accounts Receivables |
3 680
|
10 860
|
9 959
|
8 981
|
9 872
|
9 317
|
11 069
|
12 073
|
13 015
|
11 467
|
|
| Other Receivables |
715
|
1 774
|
72
|
1 875
|
2 226
|
1 499
|
1 385
|
6 825
|
1 990
|
2 556
|
|
| Inventory |
2 306
|
6 896
|
7 328
|
7 080
|
9 817
|
8 835
|
12 335
|
12 295
|
12 004
|
11 892
|
|
| Other Current Assets |
360
|
501
|
3 204
|
829
|
655
|
596
|
635
|
583
|
1 818
|
878
|
|
| Total Current Assets |
14 447
|
35 149
|
37 918
|
24 836
|
30 487
|
23 721
|
28 172
|
33 618
|
32 434
|
29 690
|
|
| PP&E Net |
4 704
|
12 349
|
11 828
|
9 868
|
11 369
|
14 639
|
14 994
|
15 136
|
13 726
|
9 585
|
|
| PP&E Gross |
0
|
12 349
|
0
|
9 868
|
11 369
|
14 639
|
14 994
|
15 136
|
13 726
|
9 585
|
|
| Accumulated Depreciation |
0
|
1 011
|
0
|
1 744
|
2 475
|
3 699
|
5 014
|
6 463
|
7 219
|
6 597
|
|
| Intangible Assets |
1 544
|
13 320
|
15 448
|
14 538
|
15 086
|
5 463
|
6 185
|
6 250
|
5 631
|
5 271
|
|
| Goodwill |
1 368
|
9 267
|
11 308
|
10 827
|
13 776
|
4 286
|
4 805
|
4 859
|
5 138
|
5 294
|
|
| Note Receivable |
1 170
|
2 026
|
1 788
|
2 070
|
2 282
|
2 152
|
1 883
|
2 106
|
1 838
|
1 858
|
|
| Long-Term Investments |
1 471
|
1 272
|
3 157
|
3 517
|
4 967
|
9 206
|
12 070
|
5 605
|
4 590
|
3 287
|
|
| Other Long-Term Assets |
101
|
1 177
|
1 295
|
1 428
|
1 828
|
2 050
|
2 039
|
2 184
|
3 029
|
3 411
|
|
| Other Assets |
1 368
|
9 267
|
11 308
|
10 827
|
13 776
|
4 286
|
4 805
|
4 859
|
5 138
|
5 294
|
|
| Total Assets |
24 805
N/A
|
74 559
+201%
|
82 742
+11%
|
67 084
-19%
|
79 797
+19%
|
61 517
-23%
|
70 150
+14%
|
69 759
-1%
|
66 384
-5%
|
58 398
-12%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2 346
|
7 754
|
7 741
|
7 121
|
8 890
|
7 977
|
11 786
|
10 715
|
9 823
|
8 516
|
|
| Accrued Liabilities |
28
|
156
|
0
|
94
|
198
|
104
|
48
|
569
|
612
|
519
|
|
| Short-Term Debt |
2 030
|
7 005
|
13 940
|
9 444
|
13 390
|
12 288
|
10 238
|
14 965
|
13 308
|
15 742
|
|
| Current Portion of Long-Term Debt |
4 213
|
2 143
|
0
|
242
|
759
|
1 481
|
2 315
|
5 064
|
3 553
|
1 996
|
|
| Other Current Liabilities |
1 405
|
1 862
|
9 358
|
2 091
|
3 385
|
3 598
|
2 996
|
2 803
|
2 605
|
2 020
|
|
| Total Current Liabilities |
10 022
|
18 920
|
31 039
|
18 993
|
26 622
|
25 449
|
27 383
|
34 117
|
29 902
|
28 793
|
|
| Long-Term Debt |
2 530
|
26 270
|
16 377
|
15 513
|
18 066
|
8 577
|
10 928
|
10 221
|
13 435
|
7 431
|
|
| Deferred Income Tax |
146
|
456
|
2 228
|
2 209
|
2 056
|
208
|
463
|
357
|
446
|
403
|
|
| Minority Interest |
139
|
502
|
1 335
|
1 546
|
1 530
|
672
|
373
|
241
|
394
|
539
|
|
| Other Liabilities |
410
|
1 833
|
4 225
|
4 186
|
5 036
|
1 337
|
3 235
|
1 231
|
873
|
1 053
|
|
| Total Liabilities |
13 247
N/A
|
47 980
+262%
|
55 203
+15%
|
42 448
-23%
|
53 310
+26%
|
36 243
-32%
|
42 384
+17%
|
46 166
+9%
|
44 262
-4%
|
37 142
-16%
|
|
| Equity | |||||||||||
| Common Stock |
596
|
893
|
894
|
895
|
895
|
896
|
897
|
898
|
903
|
919
|
|
| Retained Earnings |
609
|
3 647
|
26 644
|
6 308
|
8 854
|
7 236
|
9 522
|
4 849
|
3 073
|
1 998
|
|
| Additional Paid In Capital |
6 014
|
18 822
|
0
|
16 971
|
17 001
|
17 008
|
17 273
|
17 326
|
17 545
|
18 234
|
|
| Unrealized Security Profit/Loss |
0
|
297
|
0
|
612
|
602
|
703
|
599
|
672
|
1 300
|
1 823
|
|
| Other Equity |
4 339
|
3 513
|
0
|
1 075
|
339
|
837
|
674
|
1 192
|
1 903
|
1 928
|
|
| Total Equity |
11 558
N/A
|
26 579
+130%
|
27 539
+4%
|
24 637
-11%
|
26 487
+8%
|
25 274
-5%
|
27 767
+10%
|
23 592
-15%
|
22 123
-6%
|
21 256
-4%
|
|
| Total Liabilities & Equity |
24 805
N/A
|
74 559
+201%
|
82 742
+11%
|
67 084
-19%
|
79 797
+19%
|
61 517
-23%
|
70 150
+14%
|
69 759
-1%
|
66 384
-5%
|
58 398
-12%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
60
|
89
|
89
|
90
|
90
|
90
|
90
|
90
|
90
|
92
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
